In a mouse model of c-MYC driven liver cancer, expression of a dominant negative HSF1 downregulated c-MYC levels and lipogenesis, mitochondrial biogenesis, and glycolysis including hexokinase and lactate dehydrogenase20. Here, HSF1 is linked to liver cancer.